Article (Scientific journals)
Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial
HAUZEUR, Jean-Philippe; De Maertelaer, Viviane ; BAUDOUX, Etienne et al.
2018In International Orthopaedics, 42, p. 1429-1435
Peer Reviewed verified by ORBi
 

Files


Full Text
396.pdf
Publisher postprint (448.19 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Osteonecrosis; Femoral head; Bone marrow aspirate concentrate ; Cell therapy ; Mesenchymal stem cells; Hip
Abstract :
[en] Purpose The fracture stage of non-traumatic osteonecrosis (ON stage 3) of the femoral head (ONFH) has an unfavourable prognosis frequently requiring total hip replacement (THR). The percentage could be lowered after core decompression. In earlier non-fracture ON stages, implantation of autologous bone marrow aspirate concentrate (BMAC) improved the effect of core decompression. The purpose was to evaluate the effect of BMAC in addition to core decompression in stage 3 ONFH. Methods A double blind RCT was conducted comparing two groups: core decompression plus saline injection or core decompression plus BMAC implantation. Both patients and assessors were blinded to the treatment assignments. Evaluations were done at baseline, three, six, 12, and 24 months, including pain (VAS), WOMAC, side-effects, radiological evolution including ARCO subclassifications, together with possible THR requirement. The primary endpoint was the need for THR. The second endpoints included the clinical symptoms such as pain and functional ability and the progression of the ON lesions as well as the appearance of osteoarthritis features (ARCO stage 4). Both groups included 23 hips (19 patients). Results No differences were found between the groups for THR requirements, clinical tests, and radiological evolution. In both groups, 15/23 hips needed THR. The radiological evolution of the ONFH lesions in term of location, extension, surface collapse, and dome depression was moderate in both groups and was not correlated with the need of THR. Conclusions Implantation of BMAC after core decompression did not produce any improvement of the evolution of ONFH stage 3.
Disciplines :
Rheumatology
Author, co-author :
HAUZEUR, Jean-Philippe ;  Centre Hospitalier Universitaire de Liège - CHU > Service de rhumatologie
De Maertelaer, Viviane ;  Université Libre de Bruxelles - ULB
BAUDOUX, Etienne  ;  Centre Hospitalier Universitaire de Liège - CHU > Thérapie cellulaire
MALAISE, Michel ;  Centre Hospitalier Universitaire de Liège - CHU > Service de rhumatologie
Beguin, Yves  ;  Université de Liège - ULiège > GIGA-R : Hématologie
Gangji, Valérie;  Université Libre de Bruxelles - ULB > Hôpital Erasme > Department of Rheumatology and Physical Medicine
Language :
English
Title :
Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial
Publication date :
2018
Journal title :
International Orthopaedics
ISSN :
0341-2695
eISSN :
1432-5195
Publisher :
Springer Verlag, Berlin, Germany
Volume :
42
Pages :
1429-1435
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 11 October 2017

Statistics


Number of views
520 (11 by ULiège)
Number of downloads
799 (3 by ULiège)

Scopus citations®
 
61
Scopus citations®
without self-citations
60
OpenCitations
 
53

Bibliography


Similar publications



Contact ORBi